Curadel, LLC is a research and development (R&D) company specializing in novel devices and drugs for the treatment of cancer and other diseases. It's core ideology is "We exist to alleviate suffering"​ and its team has been carefully selected to work as a collegial and coherent group to solving some of the most difficult problems in medicine and surgery. Curadel has a particular expertise in near-infrared (NIR) fluorescence optical imaging and it scientists and engineers are responsible for many of the recent advances in the field. Curadel was founded by John V. Frangioni, M.D., Ph.D., Professor of Medicine and Professor of Radiology (currently part-time) at Harvard Medical School.